Comparison between pioglitazone and structured exercise on muscle health, circulating irisin and hepatic steatosis in male patients with type 2 diabetes and MASLD
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2026 - 2027
Project Lead
Dr. Shah Nawaz
Authors
Dr. Ganapathi Dr. Vageesh Dr. Belinda Dr Sonali Appaiah Dr. Shah Nawaz
Project Status
ongoing
Project Type
ESI